Literature DB >> 30168042

Effect of remote ischaemic conditioning on platelet aggregation and platelet turnover.

Nina Rise1,2, Jacobina Kristiansen1,2, Anne-Mette Hvas2,3, Erik L Grove1,3, Morten Würtz1, Søs Neergaard-Petersen1, Steen Dalby Kristensen4,5.   

Abstract

Remote ischaemic conditioning (RIC) is a new beneficial treatment for patients with ST-elevation myocardial infarction. RIC may inhibit thrombus formation and, therefore, we investigated whether RIC affects platelet aggregation and turnover. 30 healthy male volunteers were subjected to intervention on day 1 (sham intervention, no aspirin), day 2 (RIC, no aspirin), and day 16 (RIC, treated 7 days with aspirin 75 mg/day). RIC was performed as four cycles of 5 min interchangeable inflation and deflation using an automated cuff. Blood samples were collected 5 min before, as well as 5 and 45 min after RIC. Platelet aggregation was measured by Multiplate® using collagen (COLtest), adenosine diphosphate (ADPtest), and arachidonic acid (ASPItest) as agonists. Platelet turnover was evaluated by flow cytometry. Serum thromboxane B2 was determined by ELISA to confirm aspirin compliance. We found no significant change in platelet aggregation at visit 1 (COLtest: p = 0.32; ADPtest: p = 0.24; ASPItest: p = 0.07), visit 2, except for ADP-induced platelet aggregation evaluated 5 min after RIC (COLtest: p = 0.39; ADPtest: p = 0.02; ASPItest: p = 0.39), or visit 3 (COLtest: p = 0.48; ADPtest: p = 0.61; ASPItest: p = 0.90). Platelet turnover was not influenced by RIC, neither on nor off aspirin (all p-values > 0.07). (1) RIC did not affect platelet aggregation in healthy young men. (2) RIC did not affect platelet turnover in healthy young men. (3) Aspirin did not influence the effect of RIC on platelet aggregation and turnover. (4) Future studies exploring the effect of RIC on platelet aggregation and turnover in patients with ischaemic heart disease are warranted.

Entities:  

Keywords:  Aspirin; Ischaemic conditioning; Platelet aggregation; Platelet function tests; Platelet turnover

Mesh:

Substances:

Year:  2018        PMID: 30168042     DOI: 10.1007/s11239-018-1728-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  23 in total

1.  Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans.

Authors:  C M Pedersen; N L Cruden; M R Schmidt; C Lau; H E Bøtker; R K Kharbanda; D E Newby
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

Review 2.  Platelet turnover in atherothrombotic disease.

Authors:  Marie Lordkipanidzé
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Effect of long-term remote ischaemic conditioning on platelet function and fibrinolysis in patients with chronic ischaemic heart failure.

Authors:  Kasper Pryds; Jacobina Kristiansen; Søs Neergaard-Petersen; Roni R Nielsen; Michael R Schmidt; Jens Refsgaard; Steen D Kristensen; Hans Erik Bøtker; Anne-Mette Hvas; Erik L Grove
Journal:  Thromb Res       Date:  2017-03-10       Impact factor: 3.944

4.  Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry.

Authors:  Peter Rubak; Kirsten Villadsen; Anne-Mette Hvas
Journal:  Thromb Res       Date:  2012-07-17       Impact factor: 3.944

5.  Platelet aggregation is dependent on platelet count in patients with coronary artery disease.

Authors:  Morten Würtz; Anne-Mette Hvas; Steen Dalby Kristensen; Erik Lerkevang Grove
Journal:  Thromb Res       Date:  2011-09-13       Impact factor: 3.944

6.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

Authors:  Hans Erik Bøtker; Rajesh Kharbanda; Michael R Schmidt; Morten Bøttcher; Anne K Kaltoft; Christian J Terkelsen; Kim Munk; Niels H Andersen; Troels M Hansen; Sven Trautner; Jens Flensted Lassen; Evald Høj Christiansen; Lars R Krusell; Steen D Kristensen; Leif Thuesen; Søren S Nielsen; Michael Rehling; Henrik Toft Sørensen; Andrew N Redington; Torsten T Nielsen
Journal:  Lancet       Date:  2010-02-27       Impact factor: 79.321

7.  Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.

Authors:  E L Grove; A M Hvas; S B Mortensen; S B Larsen; S D Kristensen
Journal:  J Thromb Haemost       Date:  2011-01       Impact factor: 5.824

8.  Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention.

Authors:  Astrid D Sloth; Michael R Schmidt; Kim Munk; Rajesh K Kharbanda; Andrew N Redington; Morten Schmidt; Lars Pedersen; Henrik T Sørensen; Hans Erik Bøtker
Journal:  Eur Heart J       Date:  2013-09-12       Impact factor: 29.983

9.  Rapid evaluation of platelet function using the Multiplate® Analyzer.

Authors:  Morten Würtz; Anne-Mette Hvas; Kristian Hylleberg Christensen; Peter Rubak; Steen Dalby Kristensen; Erik Lerkevang Grove
Journal:  Platelets       Date:  2013-11-18       Impact factor: 3.862

10.  Plasma from human volunteers subjected to remote ischemic preconditioning protects human endothelial cells from hypoxia-induced cell damage.

Authors:  Nina C Weber; Isabelle Riedemann; Kirsten F Smit; Karina Zitta; Djai van de Vondervoort; Coert J Zuurbier; Markus W Hollmann; Benedikt Preckel; Martin Albrecht
Journal:  Basic Res Cardiol       Date:  2015-02-26       Impact factor: 17.165

View more
  4 in total

1.  Remote ischemic conditioning enhances oxygen supply to ischemic brain tissue in a mouse model of stroke: Role of elevated 2,3-biphosphoglycerate in erythrocytes.

Authors:  Lin Wang; Changhong Ren; Yang Li; Chen Gao; Ning Li; Haiyan Li; Di Wu; Xiaoduo He; Changqing Xia; Xunming Ji
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-15       Impact factor: 6.200

2.  Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction: a substudy of the CONDI-2/ERIC-PPCI randomized controlled trial.

Authors:  Diana A Gorog; Mohamed Farag; Nikolaos Spinthakis; Derek M Yellon; Hans Erik Bøtker; Rajesh K Kharbanda; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

Review 3.  Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target.

Authors:  Melanie Ziegler; Xiaowei Wang; Karlheinz Peter
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

4.  Effect of remote ischemic preconditioning on hemostasis and fibrinolysis in head and neck cancer surgery: A randomized controlled trial.

Authors:  Andreas Engel Krag; Birgitte Jul Kiil; Christine Lodberg Hvas; Anne-Mette Hvas
Journal:  PLoS One       Date:  2019-07-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.